Pharmaceutical business to enter new markets thanks to acquisition

Leeds-based Rosemont Pharmaceuticals has acquired Lucis Pharma Ltd, a specialist pharmaceutical business in Gloucestershire. It means Rosemont, which is backed by Inflexion private equity, will be able to expand its existing portfolio and gain access to a pipeline of innovative products providing lifesaving pharmaceuticals to the UK and overseas markets. Founded in 2012, Lucis is a provider in the development and licensing of novel and exclusive medicines. It has established a strong portfolio which, in addition to a pipelin... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
Close